3,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridazine, 97%, 5g

6-Fluoro-1,2-dihydrospiro[indole-3,4'-piperidine]-2-one hydrochloride, 1g

Tapón con cono estándar de plástico, 14/23, amarillo, 10 Unidad(es)

Ethyl 3-bromophenylacetate, 95.0%, 10g

1H-Indeno[5,4-f]quinoline-7-carboxylic acid, 3-fluoro-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1,4a,6a-triMethyl-2-oxo-, (4aS,4bS,6aS,7S,9aS,9bS,11aR)-, 98%, 10mg

(6-Ethoxy-5-methylpyridin-3-yl)boronic acid, 98%, 1g

4-(2,4-Dichloro-5-fluoro-phenyl)-thiazol-2-ylamine, 1g

2-Bromo-3,4,5-trifluoro-1-nitrobenzene, 95.0%, 25g

1-Cyclopropyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 95%, 100mg

4,6-Dichloro-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-one, 95.0%, 10g

Sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate, 50g

tert-butyl 4-(bromoacetyl)-1-piperazinecarboxylate, 95.0%, 5g

Diethyl (2-oxopropyl)phosphonate, 95.0%, 25g